Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by Valuehunter72on Jul 04, 2020 9:19am
88 Views
Post# 31223706

RE:RE:RE:RE:RE:RE:SONA ROCKET example for VXL

RE:RE:RE:RE:RE:RE:SONA ROCKET example for VXL

other catalysts might include

Advancing the cancer program/ trials
A country stepping forward with a monetary deal for the vaccine..kinda like Operation Warped Speed
FDA approval
Low cost to manufacture 
proof that it is effective against mutation 

 



Valuehunter72 wrote: VXL would have to have everything lined up for that to happen.

1. close PP and announce insider participation 
2. announcement of Strategic Innovation Funding awarded
3. Announce successful preclinical testing
4. Announce entering phase 1
5. Short and successful phase 1 data
6. More funding from SI fund
7. announce entering phase 2.
8. Successful phase 2 data
9. Announce Big Pharma manufacturing partner.  (This could come any time after step 4)
10. Enter phase 3
11. Successful phase 3

Something like this would need to play out for VXL to be any thing like Sona and like BigLicka said earlier...3 times the float.


Thats one hell of a bet....but is possible I guess.

Can anybody else add any other catalysts that I missed....like Hire PR firm.......

 

<< Previous
Bullboard Posts
Next >>